Table 4: The comparison of the Treg cells level between patients with SR and with non-SR.

Before the treatment (%)During the follow-up phase (%)

The rapamycin group
SR17
Non-SR8

The cyclosporine A group
SR11
Non-SR17

, comparing the Treg cells level before the treatment to that during the follow-up phase in the rapamycin group.